Can you answer the questions about this case ahead of joining Dr David Chascsa's session.
A 52-year-old man with a history of obesity, hypertension, and type 2 diabetes presents to the clinic for evaluation of elevated liver enzymes. He has a BMI of 34 kg/m² and a family history of liver disease. Recent blood tests reveal elevated ALT, AST, and a high FIB-4 score.
This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in USA. The content is not available for healthcare professionals in any other region.
Question 1. Given the patient's clinical presentation and test results, what is the most likely diagnosis? How would you risk-stratify this patient for disease progression?
Question 1. Given the patient's clinical presentation and test results, what is the most likely diagnosis? How would you risk-stratify this patient for disease progression?
Question 2. Which non-invasive tests would you recommend to confirm the diagnosis and assess the extent of liver fibrosis? What are the advantages and limitations of these tests?
Question 2. Which non-invasive tests would you recommend to confirm the diagnosis and assess the extent of liver fibrosis? What are the advantages and limitations of these tests?
Question 3. Discuss the potential treatment options for this patient, including lifestyle modifications, pharmacological interventions, and the role of GLP-1 receptor agonists.
Question 3. Discuss the potential treatment options for this patient, including lifestyle modifications, pharmacological interventions, and the role of GLP-1 receptor agonists.
Question 4. How would you monitor this patient's response to treatment? What non-invasive tests could be used to assess changes in liver fat content and fibrosis?
Question 4. How would you monitor this patient's response to treatment? What non-invasive tests could be used to assess changes in liver fat content and fibrosis?
Question 5. What are the key points to emphasize in patient education regarding lifestyle modifications, adherence to medications, and the importance of follow-up? How can you provide support to help the patient maintain long-term adherence to their treatment plan?
Question 5. What are the key points to emphasize in patient education regarding lifestyle modifications, adherence to medications, and the importance of follow-up? How can you provide support to help the patient maintain long-term adherence to their treatment plan?